15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups.
Duke University
Carbohydroxamido-oxazolidines: antibacterial agents that target lipid A biosynthesis.
Merck Research Laboratories
Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.
Kyorin Pharmaceutical
LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents.
Kyorin Pharmaceutical
Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors.
Duke University
Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC.
Pfizer
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
Merck Research Laboratories
Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold.
Jilin University